Cited by 137Hepatitis C virus researchHIV, Drug Use, Sexual RiskHemophilia Treatment and Research

The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study.

Open access
Brettler, DB, Mannucci, PM, Gringeri, A, Rasko, JE, Forsberg, AD, Rumi, MG, Garsia, RJ, Rickard, KA +1 more·1992·Blood

Abstract

To study the transmission rate of hepatitis C virus (HCV) in the female sexual partners of antibody-positive hemophilic males, 106 partners from three hemophilia centers located in Europe, America, and Australia were tested for HCV seropositivity using a first-generation enzyme-linked immunosorbent assay (ELISA-1) and, subsequently, a second-generation ELISA (ELISA-2) and a supplemental recombinant immunoblot assay. Additionally, the cohort was tested for the presence of antibody to the human immunodeficiency virus type-1 and hepatitis B virus markers. No female partner was HCV antibody-positive using the ELISA-1 test, whereas five were seropositive by the ELISA-2 test. Three of these five female partners were seropositive on the supplemental test, the remaining two having indeterminate results, for an overall prevalence of 2.7%. Thus, even with the use of sensitive testing, the prevalence of HCV infection remains low in this cohort, showing that the efficiency of heterosexual transmission of HCV is poor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v80.2.540.540

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Risk of HCV infection increases commensurate with increasing numbers of sex partners among heterosexual persons and MSM with HIV infection, especially if their partners are also coinfected with HIV.

    “Certain studies have revealed that risk increases commensurate with increasing numbers of sex partners among heterosexual persons (1337,1338,1351–1353) and MSM with HIV infection (1349,1354–1357), especially if their partners are also coinfected with HIV (237,1340,1354–1356,1358).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1337]

    The source addresses HIV coinfection but reaches the opposite conclusion for its cohort. In the Discussion, the authors state that they could not show an association between HIV/HCV coinfection in hemophilic men and HCV transmission to their female partners; Table 3 likewise reports no significant difference. The study does not assess whether risk rises with the number of sex partners. (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Studies have reported either no or minimally increased rates of HCV infection among partners of persons with HCV infection compared with partners of those without HCV.

    “Studies of HCV transmission between heterosexual couples and MSM have yielded mixed results; however, studies have reported either no or minimally increased rates of HCV infection among partners of persons with HCV infection compared with partners of those without HCV (1334,1336–1338).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1337]

    The Discussion reports HCV infection in 2.7% of female partners of HCV-infected hemophilic men and concludes that heterosexual transmission was inefficient. The study did not compare those partners with partners of people without HCV; its reported comparison is with blood donors, whose prevalence was four to six times lower. Thus it supports the low-rate finding, but not the claim's specified partner-to-partner comparison. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Rutter P, Rykaczewski C, McGuire MA, OBrien TA, Tupper BL, h u b P Hepatitis C antibody testing experience in a large regional blood center. Second International Symposium on HCV, Los Angeles, CA, November 8-9,1990, program (abstr B36)
  2. Operskalski EA Comparison of HCV with HBV infection among sexual and non sexual household contacts of persons with congenital clotting disorders. Second International Symposium on HCV, Los Angeles, CA, November 8-9,1990, program (abstr 80

Cited by

Sorted by citations

Authors
Brettler, D., Mannucci, P., Gringeri, A., Rasko, J., Forsberg, A., Rumi, M., Garsia, R., Rickard, K., & Colombo, M.
Affiliations
Department of Medicine, Medical Center of Central Massachusetts, Worcester 01605.
Venue
Blood
Published
1992-07-15
Volume
80
Issue
2
Pages
540-543
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W175273854
Cited by
137
References
24
Citations by year
2024: 1 · 2022: 1 · 2021: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 1
FWCI
8.20
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
Centers for Disease Control and Prevention (MCI-252002-01)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
Keywords
hepatitis C virus, HCV transmission, hemophilia, female sexual partners, heterosexual transmission, HCV seroprevalence, HCV antibody testing, recombinant immunoblot assay, HIV-1, hepatitis B virus
MeSH terms
Enzyme-Linked Immunosorbent Assay, Female, Hemophilia A, Hepatitis Antibodies, Hepatitis C, HIV Seropositivity, Humans, Male, Risk Factors, Sexual Behavior, HIV Antibodies, Transfusion Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review